PINKY PUN: Open Payments
NPI 1811677263 · MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 11 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $455 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $114 |
| Amgen Inc. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: Kerendia, REPATHA, WAINUA, VERQUVO, LEQVIO.
Industry payments across NJ — which companies pay providers there.
